A Prospective Study of Per-and Polyfluoroalkyl Substance (PFAS) Mixtures and Pregnancy Outcomes among Black Women
Project Number1K99ES036288-01A1
Former Number1K99ES036288-01
Contact PI/Project LeaderSCHILDROTH, SAMANTHA
Awardee OrganizationBOSTON UNIVERSITY MEDICAL CAMPUS
Description
Abstract Text
Project Summary/Abstract
Per- and polyfluoroalkyl substances (PFAS) are known endocrine disrupting chemicals (EDCs), and exposure
to PFAS has been associated with adverse pregnancy outcomes, including spontaneous abortion (SAB), pre-
term birth (PTB), and small for gestational age (SGA) births. However, less is known about 1) PFAS mixtures,
2) modifiable factors (e.g., perceived stress) and 3) underlying biological pathways of PFAS perinatal toxicity.
Further, less research has been devoted to understanding the impact of PFAS in Black women, who remain
understudied in environmental health research, but may have inequitable exposure to EDCs and a higher prev-
alence of adverse pregnancy outcomes. The aims of this proposal are to investigate associations of a PFAS
mixture with pregnancy outcomes (SAB, gestational age, birth size), describe the modifying role of perceived
stress, and identify the biological pathways underlying PFAS perinatal toxicity using untargeted metabolomics
data in a prospective cohort of Black women. We will leverage existing data from the Study of Environment,
Lifestyle, and Fibroids (SELF), which is a cohort of reproductive-aged Black women from Detroit, MI. Partici-
pants were recruited between 2010 and 2012 and were 23-35 years at enrollment. PFAS concentrations were
measured in baseline plasma samples; pregnancy outcomes were prospectively assessed using structured
questionnaires at follow-up visits; and all covariate data were collected in questionnaires or clinic visits at base-
line and each follow-up visit. In the K99 phase of the award, Dr. Samantha Schildroth (PI) proposes the follow-
ing aims: 1) evaluate the association of a PFAS mixture with pregnancy outcomes (SAB, gestational age, birth
size); and 1B) in a sub-aim, examine perceived stress scores as a modifier of the PFAS mixture. The R00
phase of the award will build on the K99 phase by identifying biological pathways related to PFAS toxicity. This
phase of the award will address the following aims: 2) identify metabolic pathways associated with PFAS using
metabolomics data; 3A) quantify the mediating pathway(s) between the PFAS mixture and pregnancy out-
comes that operate through metabolites identified in Aim 2; and 3B) in a sub-aim, examine the role of per-
ceived stress as a modifier of the mediating pathway(s) identified in Aim 3A. The research in this proposal will
address critical knowledge gaps in the literature by assessing the perinatal toxicity of PFAS mixtures in Black
women, which will serve to inform public health interventions aimed at reducing inequities in adverse preg-
nancy outcomes. In addition, this award will provide Dr. Schildroth with foundational training in perinatal epide-
miology, metabolomics, environmental toxicology, and modifiable psychosocial factors under the guidance of
an expert, interdisciplinary team of researchers, allowing for her successful transition into an independent re-
searcher focused at the nexus of chemical mixtures, metabolomics, and women’s and children’s health.
Public Health Relevance Statement
Project Narrative
Per- and polyfluoroalkyl substances (PFAS) are known endocrine disrupting chemicals that have been
associated with adverse pregnancy outcomes, but less is known about their mixture, modifiable factors (e.g.,
perceived stress), and underlying biological pathways of toxicity, especially in Black women. This study aims to
assess the association of a PFAS mixture with adverse pregnancy outcomes, examine perceived stress as a
modifier of the PFAS mixture, and identify biological pathways underlying toxicity using untargeted
metabolomics data in a prospective cohort of reproductive-aged Black women. The findings from this study will
help to inform the current understanding of PFAS perinatal toxicity and public health interventions aimed at
reducing inequities in adverse pregnancy outcomes among Black women.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AccountingAddressAdverse effectsAffectAmino AcidsAnimalsAwardBiologicalBiological MarkersBirthChemicalsChild HealthClinic VisitsConceptionsDataEndocrineEndocrine DisruptorsEndocrine disruptionEndocrine systemEnrollmentEnvironmentEnvironmental ExposureEnvironmental HealthEpidemiologyEtiologyExposure toFibroid TumorFundingFutureGestational AgeGoalsHealth Care CostsHealth Care SystemsHigh PrevalenceHormonalIndividualIndustrial ProductInequityInfantJointsKnowledgeLife StyleLiteratureMeasuresMediatingMediationMediatorMetabolic PathwayMethodsNational Institute of Environmental Health SciencesOutcomeParticipantPathway interactionsPerinatalPerinatal EpidemiologyPhasePlasmaPlayPoly-fluoroalkyl substancesPregnancyPregnancy OutcomePremature BirthProspective StudiesProspective cohortProspective, cohort studyPsychosocial FactorQuestionnairesResearchResearch PersonnelRisk FactorsRoleSample SizeSamplingSmall for Gestational Age InfantSocietiesSpontaneous abortionStructureToxic effectTrainingVisitWhite WomenWomanWorkadverse pregnancy outcomeagedblack womencareercohortconsumer productenvironmental chemicalenvironmental toxicologyepidemiologic dataexperienceexposed human populationfollow-uphormone metabolismlipid metabolismmetabolomicsnovelperceived stresspostpartum healthprospectivepublic health interventionracismrecruitreproductivesubstance usetoxicant
National Institute of Environmental Health Sciences
CFDA Code
113
DUNS Number
604483045
UEI
FBYMGMHW4X95
Project Start Date
15-December-2024
Project End Date
30-November-2026
Budget Start Date
15-December-2024
Budget End Date
30-November-2025
Project Funding Information for 2025
Total Funding
$121,057
Direct Costs
$112,090
Indirect Costs
$8,967
Year
Funding IC
FY Total Cost by IC
2025
National Institute of Environmental Health Sciences
$121,057
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1K99ES036288-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1K99ES036288-01A1
Patents
No Patents information available for 1K99ES036288-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1K99ES036288-01A1
Clinical Studies
No Clinical Studies information available for 1K99ES036288-01A1
News and More
Related News Releases
No news release information available for 1K99ES036288-01A1
History
No Historical information available for 1K99ES036288-01A1
Similar Projects
No Similar Projects information available for 1K99ES036288-01A1